Drug Shortage Report for RAN-LISINOPRIL
Report ID | 108171 |
Drug Identification Number | 02294230 |
Brand name | RAN-LISINOPRIL |
Common or Proper name | LISINOPRIL |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | LISINOPRIL |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-06 |
Estimated end date | 2020-06-30 |
Actual end date | 2020-05-08 |
Shortage status | Resolved |
Updated date | 2020-05-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-05-14 | French | Compare |
v3 | 2020-05-14 | English | Compare |
v2 | 2020-03-07 | French | Compare |
v1 | 2020-03-07 | English | Compare |
Showing 1 to 4 of 4